Search

Your search keyword '"Traverse-Glehen, A."' showing total 1,211 results

Search Constraints

Start Over You searched for: Author "Traverse-Glehen, A." Remove constraint Author: "Traverse-Glehen, A."
1,211 results on '"Traverse-Glehen, A."'

Search Results

1. Anti-RGS8 paraneoplastic cerebellar ataxia is preferentially associated with a particular subtype of Hodgkin’s lymphoma

2. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE

3. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

4. Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study

5. Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective study

8. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

9. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

10. Deep phenotyping of nodal T-cell lymphomas reveals immune alterations and therapeutic targets

11. The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients

12. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

13. High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma

14. Carbon footprint evaluation of routine anatomic pathology practices using eco-audit: Current status and mitigation strategies

17. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1

18. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma

19. Clinical presentation, outcome, and prognostic markers in patients with intravascular large B‐cell lymphoma, a lymphoma study association (LYSA) retrospective study

20. P1243: FUNCTIONAL PRECISION ONCOLOGY FOR FOLLICULAR LYMPHOMA WITH PATIENT-DERIVED XENOGRAFT IN AVIAN EMBRYOS.

21. Lymph node excisions provide more precise lymphoma diagnoses than core biopsies: a French Lymphopath network survey

23. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

25. Genetic and phenotypic attributes of splenic marginal zone lymphoma

26. Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study

27. Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

28. Identification of primary mediastinal B-cell lymphomas with higher clonal dominance and poorer outcome using 5′RACE

29. Mutational landscape of gray zone lymphoma

30. New Insights into the Biology and Diagnosis of Splenic Marginal Zone Lymphomas

31. Hodgkin Lymphoma, Classical

32. Gene expression profiling of gray zone lymphoma

33. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma

34. High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline

35. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant–associated ALCL

36. Association Between Microscopic Lesions at Ileal Resection Margin and Recurrence After Surgery in Patients With Crohn’s Disease

42. Significance of Primary Melanoma Regression on Local Infiltrate and Outcome

43. Crystal‐storing histiocytosis and Bing‐Neel‐like syndrome revealing a small B‐cell lymphoma with plasmacytic differentiation, presumed to be a marginal zone lymphoma

44. Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation

45. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

47. Integrated spatial and multimodal single‐cell transcriptomics reveal patient‐dependent cell heterogeneity in splenic marginal zone lymphoma.

48. PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

50. Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing

Catalog

Books, media, physical & digital resources